FDAnews Device Daily Bulletin
Medical Devices / Commercial Operations

DT MedTech Gets CE Marking and Begins Selling of Hintermann Series H3 Devices

Aug. 17, 2016
A A

DT MedTech has been granted CE Marking for the Hintermann Series H3 total ankle replacement devices and are now selling and distributing their products outside the U.S. market.

The series includes: the Hintermann series H3 three-piece total ankle replacement prosthesis, which comprises the standard, sensitive, and revision systems; the Kalix II subtalar arthrodesis implant to treat flatfoot deformities; and instrumentation to support the implantable devices.

The Hintermann series product line now is approved for use in 27 countries, including those in the EU. — Cynthia Jessup

View today's stories